HK2 and non-small cell lung carcinoma: The glycolytic enzymes hexokinase 2 (HK2) and the M2 isoform of pyruvate kinase (PKM2) were also shown to be substrates of CMA degradation, in ovarian and non-small cell lung cancers, respectively (203, 204).